Odyssey Health, Inc. (ODYY) Research

Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products. Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screening, alongside the "Save A Life" line of devices engineered for choking emergencies. Additionally, the company is advancing neurosteroid drug compounds, PRV-001 and PRV-002, intended for the treatment of concussive injuries and various rare brain disorders. The organization, established in 2014 and headquartered in Las Vegas, Nevada, was previously known as Odyssey Group International, Inc.

Market snapshot

Symbol
ODYY
Price
$0.02
Day change
+58.88%
Market cap
$1.7M
P/E ratio
-0.51x
52-week range
0.005-0.125
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • ADM Tronics Unlimited, Inc. (ADMT)
  • AI/ML Innovations Inc. (AIMLF)
  • Cellbxhealth PLC (ANPCF)
  • Bright Green Corporation (BGXX)
  • Chimeric Therapeutics Limited (CHMMF)
  • Curative Biotechnology, Inc. (CUBT)
  • Golden Valley Development, Inc (GVDI)
  • Innovative MedTech Inc. (IMTH)

Recent insider activity

  • FARRELL CHRISTINE — A-Award (500000 shares) on 2024-06-28
  • RICHARDSON RICKY — A-Award (300000 shares) on 2024-06-28
  • Casey Jerome H — A-Award (300000 shares) on 2024-06-28
  • REDMOND J MICHAEL — A-Award (500000 shares) on 2024-06-28
  • Gironda Gregory W — A-Award (250000 shares) on 2024-06-28

Open Odyssey Health, Inc. (ODYY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.